Booster Therapeutics (Germany) focuses on developing small-molecule proteasome activators for neurodegenerative disease using ...
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
Introduction The increasing incidence of type 2 diabetes mellitus (T2DM) among women of reproductive age poses significant health risks for both mothers and their fetuses. Optimising blood glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback